A phase II trial of y-90 radioembolization in patients with progressive hepatic metastases from neuroendocrine carcinoma at an NCI-designated comprehensive cancer center.
Vaibhav Sahai
No relevant relationships to disclose
Halla Sayed Nimeiri
No relevant relationships to disclose
Mary Frances Mulcahy
No relevant relationships to disclose
Riad Salem
No relevant relationships to disclose
Al Bowen Benson
No relevant relationships to disclose